Published in Atherosclerosis on March 04, 2008
To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers. Brain Behav Immun (2009) 3.00
Lifestyle risk factors and new-onset diabetes mellitus in older adults: the cardiovascular health study. Arch Intern Med (2009) 2.72
Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking? Thorax (2011) 1.60
Association between inflammatory-related disease burden and frailty: results from the Women's Health and Aging Studies (WHAS) I and II. Arch Gerontol Geriatr (2011) 1.31
Central adiposity rather than total adiposity measurements are specifically involved in the inflammatory status from healthy young adults. Inflammation (2011) 1.15
Atrial fibrillation incidence and risk factors in relation to race-ethnicity and the population attributable fraction of atrial fibrillation risk factors: the Multi-Ethnic Study of Atherosclerosis. Ann Epidemiol (2014) 0.98
Effects of interleukin-10 polymorphisms, Helicobacter pylori infection, and smoking on the risk of noncardia gastric cancer. PLoS One (2012) 0.97
Interactions between smoking, pulmonary surfactant protein B, and atherosclerosis in the general population: the Dallas Heart Study. Arterioscler Thromb Vasc Biol (2011) 0.97
The role of TNF genetic variants and the interaction with cigarette smoking for gastric cancer risk: a nested case-control study. BMC Cancer (2009) 0.95
The impact of shift work induced chronic circadian disruption on IL-6 and TNF-alpha immune responses. J Occup Med Toxicol (2010) 0.93
Acrolein exposure is associated with increased cardiovascular disease risk. J Am Heart Assoc (2014) 0.93
Clinical correlates of change in inflammatory biomarkers: The Framingham Heart Study. Atherosclerosis (2013) 0.92
Target population for clinical trials on sarcopenia. J Nutr Health Aging (2008) 0.92
Host factors associated with serologic inflammatory markers assessed using multiplex assays. Cytokine (2016) 0.92
Factors associated with inflammation markers, a cross-sectional analysis. Cytokine (2011) 0.89
Effect of mild-to-moderate smoking on viral load, cytokines, oxidative stress, and cytochrome P450 enzymes in HIV-infected individuals. PLoS One (2015) 0.87
Study of cardiovascular disease biomarkers among tobacco consumers, part 2: biomarkers of biological effect. Inhal Toxicol (2015) 0.86
Exposure to Fine Particulate Air Pollution Is Associated with Endothelial Injury and Systemic Inflammation. Circ Res (2016) 0.83
Poor self-reported health and its association with biomarkers among Canadian Inuit. Int J Circumpolar Health (2012) 0.81
Potential pathways by which maternal second-hand smoke exposure during pregnancy causes full-term low birth weight. Sci Rep (2016) 0.78
Plasma concentrations of soluble CD40 ligand in smokers with acute myocardial infarction: a pilot study. Heart Vessels (2010) 0.78
Cigarette Smoking and Chronic Kidney Disease in African Americans in the Jackson Heart Study. J Am Heart Assoc (2016) 0.76
Mediation role of C-reactive protein on the association between smoking quantity and type 2 diabetes in current Chinese smokers. J Diabetes Res (2014) 0.76
Smoking and diabetes: is the association mediated by adiponectin, leptin, or C-reactive protein? J Epidemiol (2014) 0.75
The relationship between smoking intensity and subclinical cardiovascular injury: The Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis (2017) 0.75
The association between cigarette smoking and inflammation: The Genetic Epidemiology Network of Arteriopathy (GENOA) study. PLoS One (2017) 0.75
Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes. Circ Res (2017) 0.75
The Framingham Offspring Study. Design and preliminary data. Prev Med (1975) 10.53
Probability of stroke: a risk profile from the Framingham Study. Stroke (1991) 10.14
The Sleep Heart Health Study: design, rationale, and methods. Sleep (1997) 7.55
Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol (2003) 7.47
The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol (2004) 6.44
An approach to longitudinal studies in a community: the Framingham Study. Ann N Y Acad Sci (1963) 6.29
Social inequalities in male mortality, and in male mortality from smoking: indirect estimation from national death rates in England and Wales, Poland, and North America. Lancet (2006) 5.70
Anti-inflammatory cytokines. Chest (2000) 4.74
MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature (1999) 4.19
Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation (2006) 3.15
Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax (2004) 2.85
Cigarette smoking among adults--United States, 2003. MMWR Morb Mortal Wkly Rep (2005) 2.72
Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. Circulation (1997) 2.54
Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med (2003) 2.22
Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J (2005) 2.21
Tumor necrosis factor-alpha is central to acute cigarette smoke-induced inflammation and connective tissue breakdown. Am J Respir Crit Care Med (2002) 2.00
The interactions between cigarette smoking and reduced lung function on systemic inflammation. Chest (2005) 1.91
Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol (1997) 1.90
CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study. Circulation (2005) 1.76
Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol (2002) 1.73
Exposure to secondhand smoke and biomarkers of cardiovascular disease risk in never-smoking adults. Circulation (2007) 1.63
Active smoking and a history of smoking are associated with enhanced prostaglandin F(2alpha), interleukin-6 and F2-isoprostane formation in elderly men. Atherosclerosis (2005) 1.49
Smoking trends among adolescents from 1990 to 2002 in ten European countries and Canada. BMC Public Health (2006) 1.48
The year in atherothrombosis. J Am Coll Cardiol (2004) 1.47
Smoking and inequalities. Lancet (2006) 1.30
Cigarette smoking and atherosclerosis in autopsied men. Atherosclerosis (1976) 1.23
Low-grade inflammation, thrombogenicity, and atherogenic lipid profile in cigarette smokers. Circ J (2006) 1.19
Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis. Trends Pharmacol Sci (2005) 1.09
Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study. Arterioscler Thromb Vasc Biol (2005) 1.06
The response of human bone marrow to chronic cigarette smoking. Eur Respir J (2000) 1.05
Respiratory epithelial permeability after cigarette smoke exposure in guinea pigs. J Appl Physiol (1985) (1989) 1.02
Differences of soluble CD40L in sera and plasma: implications on CD40L assay as a marker of thrombotic risk. Thromb Res (2004) 1.01
Heritability and correlates of intercellular adhesion molecule-1 in the Framingham Offspring Study. J Am Coll Cardiol (2004) 0.98
Smoking, fat mass and activation of the tumor necrosis factor-alpha pathway. Int J Obes Relat Metab Disord (2003) 0.89
Neutrophil kinetics during active cigarette smoking in rabbits. J Appl Physiol (1985) (1991) 0.87
Cigarette smoking and inflammatory indices in coronary artery disease. Int J Cardiol (2004) 0.81
Acute cigarette smoke exposure alters lung eicosanoid and inflammatory cell concentrations in rabbits. Exp Lung Res (1988) 0.79
Combined effects of smoking and hypercholesterolemia on inflammatory process, thrombosis/fibrinolysis system, and forearm hyperemic response. Am J Cardiol (2004) 0.79
High neutrophil myeloperoxidase content in smokers. Blood (1992) 0.77
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol (2002) 16.25
Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med (2006) 15.60
Vitamin D deficiency and risk of cardiovascular disease. Circulation (2008) 13.39
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Obesity and the risk of heart failure. N Engl J Med (2002) 12.58
Metabolite profiles and the risk of developing diabetes. Nat Med (2011) 12.22
Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Long-term trends in the incidence of and survival with heart failure. N Engl J Med (2002) 10.37
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14
The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol (2007) 9.90
Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation (2010) 9.09
Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation (2004) 8.80
Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation (2002) 8.49
Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension (2004) 8.27
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol (2003) 7.47
Predictors of new-onset kidney disease in a community-based population. JAMA (2004) 7.45
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet (2009) 7.27
Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med (2004) 7.12
Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA (2002) 6.84
Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation (2003) 6.83
Obesity and the risk of new-onset atrial fibrillation. JAMA (2004) 6.73
Role of oxidative modifications in atherosclerosis. Physiol Rev (2004) 6.73
The clinical implications of endothelial dysfunction. J Am Coll Cardiol (2003) 6.71
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet (2006) 6.39
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2012) 6.24
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2013) 6.13
Aortic stiffness, blood pressure progression, and incident hypertension. JAMA (2012) 6.01
Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation (2006) 5.97
Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet (2008) 5.89
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26
Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. JAMA (2009) 5.22
Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet (2009) 5.20
Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation (2007) 5.10
The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports. BMC Med Genet (2007) 5.02
Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med (2004) 4.92
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet (2012) 4.87
Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA (2004) 4.85
Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet (2009) 4.78
A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA (2003) 4.77
Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation (2004) 4.73
Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation (2008) 4.69
Incidence and prognosis of syncope. N Engl J Med (2002) 4.69
Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA (2005) 4.64
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet (2012) 4.63
Predicting the 30-year risk of cardiovascular disease: the framingham heart study. Circulation (2009) 4.62
A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study. Ann Intern Med (2008) 4.61
Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation (2013) 4.60
Local shear stress and brachial artery flow-mediated dilation: the Framingham Heart Study. Hypertension (2004) 4.56
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2010) 4.56
Impact of obesity on plasma natriuretic peptide levels. Circulation (2004) 4.46
Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med (2006) 4.36
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation (2007) 4.16
Predictive value of reactive hyperemia for cardiovascular events in patients with peripheral arterial disease undergoing vascular surgery. Arterioscler Thromb Vasc Biol (2007) 4.13
Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation (2003) 4.09